The Columbus Municipal Waste-to-Energy (Columbus WTE) facility in Columbus, Ohio, began operation in June, 1983 and ceased operation in December, 1994. During its operation, it was estimated to have released nearly 1,000 grams of dioxin Toxic Equivalents (TEQs) per year. This compares to a 1994 estimate of 9,300 g TEQ/yr from all sources emitting dioxins into the air in the United States (EPA, 1994), and to total releases of dioxins near or below 1,000 grams TEQ/Yr for England (Eduljee and Keyke, 1996), Belgium (Wevers and De Fre, 1995), and West Germany (Fiedler and Hutzinger, 1992). Because of the magnitude of emissions from this single source, studies were undertaken to evaluate the impacts to air and soil near the incinerator. This paper presents analyses evaluating dioxin concentrations and profiles in four media: stack gas, ambient air within 3 km of the incinerator, soil samples up to 8 km from the incinerator, and incinerator ash. Principal findings include: 1) an "incinerator signature" profile, as defined by stack gas emissions, was found in the ash and in subsets of the air and soil matrices, 2) soil concentrations declined from directly outside the incinerator property to the city at large, 3) an urban background soil concentration of dioxin Toxic Equivalents (TEQs) was estimated at 4 pg/g, while concentrations generally within 2 km of the incinerator ranged from 4-60 pg TEQ/g, 4) an urban background air concentration was estimated at 0.05 pg TEQ/m3, while air concentrations at a specific location about 2 km in the downwind direction of the incinerator had concentrations of 0.17 and 0.35 pg TEQ/m3 during two sampling dates, 5) analysis of the soil monitoring data in combination with the stack test data suggests that less than 2% of emitted dioxins can be found in the soil near the incinerator, and 6) principal component analysis suggests that the fraction of total concentration of OCDD is the single feature explaining most of the variation of all concentration profiles. This paper discusses these and other findings, and their implications.

Air Pollution↗

PubMedDate not supplied

Umbilical and uterine artery flow velocity waveforms in pregnant women with systemic lupus erythematosus treated with aspirin and glucocorticosteroids.

Pregnancy in systemic lupus erythematosus (SLE) is at high risk to the mother and fetus. Impaired utero-placental perfusion may increase fetal loss and intrauterine growth retardation. We assessed the changes in impedance to blood flow in the umbilical and uterine arteries in five patients with SLE treated with low dose aspirin and corticosteroids, using Doppler ultrasound longitudinally throughout pregnancy. Blood flow velocity waveforms of the umbilical and uterine arteries were studied by transabdominal and transvaginal Doppler ultrasound, respectively. Resistance index (RI) was measured every two to four weeks from week 10 to term, and the values obtained were compared to those of normal pregnancies. All five patients delivered uneventfully. One neonate was delivered at 36 weeks (2550 g) and one neonate was growth retarded (1900 g at 38 weeks). Three women delivered at 39 weeks (3585 g, 2850 g, and 2800 g). Most umbilical artery RI values obtained throughout pregnancy were above the 95th percentile of normal pregnancies. The highest values of RI of the umbilical artery were assessed in the case of fetal growth retardation. However, most measurements of RI of the uterine artery were under the 95th percentile of normal. The improved pregnancy outcome in patients with SLE treated with aspirin and corticosteroids seems to correlate with their normal uterine artery flow velocity wave forms.

Abortion, Habitual↗

PubMedDate not supplied

Azathioprine fever.

Explore the source record for details and available documents.

Aged↗

PubMedDate not supplied

ELISA determined IgM and IgA rheumatoid factors in seronegative rheumatoid and psoriatic arthritis.

Previous studies have strongly suggested an association between rheumatoid factors (RF's), particularly IgA-RF, and the presence of erosions in rheumatoid arthritis (RA). The present study was aimed at studying this association in seronegative erosive arthritides. Forty-eight patients with seronegative arthritis were evaluated for the presence of IgM- and IgA-RFs using an enzyme linked immunosorbent assay (ELISA). Twenty-nine had seronegative RA and nineteen had psoriatic arthritis (PA). Twelve (41%) seronegative RA patients were found to be seropositive for IgM- or IgA-RF. Only 1 (7%) patient with PSA was positive for IgA-RF alone. Fifteen (51%) of the RA patients and eight (42%) of the PSA patients had erosive disease. A significant correlation between IgA-RF alone and erosive disease was found only in the seronegative RA patient (p less than 0.02). We conclude that in PSA patients there appears to be no need to define isotype specific RFs. On the other hand, our findings indicate that an early detection of IgA-RF can have clinical importance in seronegative rheumatoid arthritis, as it may constitute an indication for the timely institution of disease-modifying drugs in these patients.

Adult↗

PubMedDate not supplied

Adult-type Gaucher's disease: a secondary disorder of iron metabolism.

Explore the source record for details and available documents.

Age Factors↗

PubMedDate not supplied

A protocol for a dental student experiment on human saliva and salivary secretion.

Explore the source record for details and available documents.

Humans↗

PubMedDate not supplied

Features of SLE in various ethnic groups in Israel.

OBJECTIVE: To assess the association between the ethnic origin of patients with SLE living in Israel, and the clinical and laboratory features of SLE. METHODS: A retrospective review of medical records was carried out. Patients were classified into 3 groups based on their ethnic origin: a) Ashkenazi Jews, b) Sepharadic Jews and c) Arabs. RESULTS: The study included 74 consecutive SLE patients, 69 (93%) women and 5 (7%) men. Their mean age at diagnosis was 32 years and their mean disease duration was 6.4 years. There were 21 (28%) Ashkenazi Jews, 31 (42%) Sepharadic Jews and 22 (30%) Arabs. The demographics, the frequency of various clinical and laboratory variables of SLE, and the mean disease activity index score (SLEDA1) of the three groups were not statistically different. CONCLUSION: The ethnic origin of SLE patients living in Israel is not associated with the clinical and laboratory features of the disease.

Adult↗